Company
Abingworth
Investments
| Company | Round | Date | Lead |
|---|---|---|---|
| R1 Therapeutics | Series A | 2026-03-17 | Lead |
| Addition Therapeutics | Funding | 2025-12-17 | |
| Solve Therapeutics | Funding | 2025-11-17 | |
| Iambic | Funding | 2025-11-11 | |
| Wugen | Funding | 2025-08-28 | |
| Antares Therapeutics | Series A | 2025-06-11 | |
| Glycomine | Series C | 2025-04-16 | |
| Atsena Therapeutics | Series C | 2025-04-04 | |
| Timberlyne Therapeutics | Series A | 2025-01-10 | Lead |
| Scorpion Therapeutics | Series C Financing | 2024-07-16 | Lead |
| Iambic | Series B | 2024-06-19 | Lead |
| Iambic | Series B Financing | 2023-10-06 | Lead |